Cargando…
Cross-Adversarial Learning for Molecular Generation in Drug Design
Molecular generation is an important but challenging task in drug design, as it requires optimization of chemical compound structures as well as many complex properties. Most of the existing methods use deep learning models to generate molecular representations. However, these methods are faced with...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815768/ https://www.ncbi.nlm.nih.gov/pubmed/35126153 http://dx.doi.org/10.3389/fphar.2021.827606 |
_version_ | 1784645304884133888 |
---|---|
author | Wu, Banghua Li, Linjie Cui, Yue Zheng, Kai |
author_facet | Wu, Banghua Li, Linjie Cui, Yue Zheng, Kai |
author_sort | Wu, Banghua |
collection | PubMed |
description | Molecular generation is an important but challenging task in drug design, as it requires optimization of chemical compound structures as well as many complex properties. Most of the existing methods use deep learning models to generate molecular representations. However, these methods are faced with the problems of generation validity and semantic information of labels. Considering these challenges, we propose a cross-adversarial learning method for molecular generation, CRAG for short, which integrates both the facticity of VAE-based methods and the diversity of GAN-based methods to further exploit the complex properties of Molecules. To be specific, an adversarially regularized encoder-decoder is used to transform molecules from simplified molecular input linear entry specification (SMILES) into discrete variables. Then, the discrete variables are trained to predict property and generate adversarial samples through projected gradient descent with corresponding labels. Our CRAG is trained using an adversarial pattern. Extensive experiments on two widely used benchmarks have demonstrated the effectiveness of our proposed method on a wide spectrum of metrics. We also utilize a novel metric named Novel/Sample to measure the overall generation effectiveness of models. Therefore, CRAG is promising for AI-based molecular design in various chemical applications. |
format | Online Article Text |
id | pubmed-8815768 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88157682022-02-05 Cross-Adversarial Learning for Molecular Generation in Drug Design Wu, Banghua Li, Linjie Cui, Yue Zheng, Kai Front Pharmacol Pharmacology Molecular generation is an important but challenging task in drug design, as it requires optimization of chemical compound structures as well as many complex properties. Most of the existing methods use deep learning models to generate molecular representations. However, these methods are faced with the problems of generation validity and semantic information of labels. Considering these challenges, we propose a cross-adversarial learning method for molecular generation, CRAG for short, which integrates both the facticity of VAE-based methods and the diversity of GAN-based methods to further exploit the complex properties of Molecules. To be specific, an adversarially regularized encoder-decoder is used to transform molecules from simplified molecular input linear entry specification (SMILES) into discrete variables. Then, the discrete variables are trained to predict property and generate adversarial samples through projected gradient descent with corresponding labels. Our CRAG is trained using an adversarial pattern. Extensive experiments on two widely used benchmarks have demonstrated the effectiveness of our proposed method on a wide spectrum of metrics. We also utilize a novel metric named Novel/Sample to measure the overall generation effectiveness of models. Therefore, CRAG is promising for AI-based molecular design in various chemical applications. Frontiers Media S.A. 2022-01-21 /pmc/articles/PMC8815768/ /pubmed/35126153 http://dx.doi.org/10.3389/fphar.2021.827606 Text en Copyright © 2022 Wu, Li, Cui and Zheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Wu, Banghua Li, Linjie Cui, Yue Zheng, Kai Cross-Adversarial Learning for Molecular Generation in Drug Design |
title | Cross-Adversarial Learning for Molecular Generation in Drug Design |
title_full | Cross-Adversarial Learning for Molecular Generation in Drug Design |
title_fullStr | Cross-Adversarial Learning for Molecular Generation in Drug Design |
title_full_unstemmed | Cross-Adversarial Learning for Molecular Generation in Drug Design |
title_short | Cross-Adversarial Learning for Molecular Generation in Drug Design |
title_sort | cross-adversarial learning for molecular generation in drug design |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815768/ https://www.ncbi.nlm.nih.gov/pubmed/35126153 http://dx.doi.org/10.3389/fphar.2021.827606 |
work_keys_str_mv | AT wubanghua crossadversariallearningformoleculargenerationindrugdesign AT lilinjie crossadversariallearningformoleculargenerationindrugdesign AT cuiyue crossadversariallearningformoleculargenerationindrugdesign AT zhengkai crossadversariallearningformoleculargenerationindrugdesign |